Since plenty of cardiac surgeries are performed annually, and a relationship exists between proper control of postoperative pain and improvement in clinical outcomes, anesthesiologists need to make progress in learning a variety of anesthesia and pain control techniques (
1). Several factors contribute to postoperative pain, including sternotomy, retraction of sternum and rib, pericardiotomy, harvest of internal mammary artery, harvest of saphenous vein, manipulation during surgery on parietal pleura, insert chest tube, and other musculoskeletal injuries during surgery. Gold standard for pain control after cardiac surgery is usually based on opioids that are associated with side effects such as constipation, nausea and vomiting, dizziness and mental confusion, and respiratory depression, which can affect the patient's initial recovery and discharge time(
2,
3). Poor treatment of acute pain affects both the patient's health and the progression of acute pain to chronic pain (
4,
5). Injectable NSAIDs, such as ketorolac, can cause gastrointestinal ulcers, renal failure, and platelet dysfunction. Therefore, it is important to know the drugs that do not cause these problems. Dexmedetomidine has been proven that improves analgesia and anesthesia and reduce the need for opioids (
6,
7). It can inhibit nausea and vomiting, and shivering after surgery. It also reduces postoperative delirium. This drug, when is used alone, can cause analgesia and sedation without respiratory depression. Paracetamol is a drug with analgesic and antipyretic effects, with no anti-inflammatory effects (
8) It is a logical analgesic for mild to moderate pain after surgery, but in severe pain should be used with other drugs (
9,
10). In this study, we aimed to evaluate the effect of these drugs on analgesia after cardiac surgery.